journal article·2025-02Open access

Multifunctional nanoparticles confers both multiple inflammatory mediators scavenging and macrophage polarization for sepsis therapy

Wenjie Xi, Weijie Wu, Lili Zhou, Qi Zhang, Shushu Yang, Lihong Huang, Yijun Lu, Jing Wang, Xinjin Chi, Yang Kang

Abstract

Sepsis is a serious and life-threatening condition, which can lead to organ failure and death clinically. Abnormally increased cell-free DNA (cfDNA) and inflammatory cytokines are involved in the development and progression of sepsis. Thus, cfDNA clearance and down-regulation of inflammatory factors are essential for the effective treatment of sepsis. Here we designed and constructed a polydopamine-based multifunctional nanoparticle for the treatment of sepsis. These nanoparticles (NPs) are composed of polydopamine (PDA) grafted with cationic polyethyleneimine (PEI). On the one hand, the NPs can utilize the electrostatic interaction to effectively adsorb cfDNA in blood, then effectively inhibiting the activation of toll like receptors (TLRs) and nuclear factor kappa B (NF-κB) pathways induced by cfDNA. On the other hand, the NPs have an immunomodulatory function, which can effectively convert pro-inflammatory macrophage (M1) into anti-inflammatory macrophage (M2), thus reduce the release of inflammatory cytokines and slow down the inflammatory storm of sepsis. In addition, the NPs possess good reactive oxygen species (ROS) scavenging ability. Briefly, the effective treatment of sepsis can be achieved by multiple strategies of effectively capturing the inflammatory triggering factor cfDNA, modulating the polarization of M1 macrophage to M2 macrophage and scavenging ROS, which has a promising clinical application. Sepsis is a serious and life-threatening condition that can arise from an infection, which can lead to organ failure and death in clinic. Abnormally increased cell-free DNA (cfDNA), massive accumulation of reactive oxygen species (ROS), increased pro-inflammatory macrophages and inflammatory cytokines are involved in the development and progression of sepsis. Thus, clearance of these inflammatory mediators and down-regulation of inflammatory factors are essential for the effective treatment of sepsis. Multifunctional nanoparticle with cfDNA scavenging, ROS scavenging and immunomodulatory functions can be effective in the treatment of sepsis and have good prospects for clinical application. • Construction of multifunctional nanoparticle based on polydopamine. • Scavenging ROS, capturing cell free DNA, and relieving inflammatory cytokine storm. • Transforming macrophages from M1 to M2 and regulating inflammatory microenvironment. • Reducing multiple organ damage and improving the survival rate of septic mice. • Excellent anti-inflammatory ability and favorable biosafety.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Inflammation biomarkers and pathways · Immune cells in cancer · Immune Response and Inflammation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (57)

Show source-provided references
1. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-201410.1001/jama.2017.13836 ↗
2. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock
3. News Feature: the quest to solve sepsis10.1073/pnas.1803551115 ↗
4. Severe sepsis and septic shock10.1056/NEJMra1208623 ↗
5. The pathophysiology and treatment of sepsis10.1056/NEJMra021333 ↗
6. Systemic inflammatory response syndrome criteria in defining severe sepsis10.1056/NEJMoa1415236 ↗
7. Small-molecule modulators of toll-like receptors10.1021/acs.accounts.9b00631 ↗
8. The immunopathology of sepsis and potential therapeutic targets10.1038/nri.2017.36 ↗
9. The inflammatory response in sepsis10.1016/j.it.2012.09.004 ↗
10. Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock10.1373/clinchem.2007.101030 ↗
11. Toll-like receptor 9 plays a pivotal role in angiotensin II-induced atherosclerosis10.1161/JAHA.118.010860 ↗
12. Toll-like receptor 4 modulation as a strategy to treat sepsis10.1155/2010/568396 ↗
13. Marine compounds with therapeutic potential in gram-negative sepsis10.3390/md11062216 ↗
14. The nexus of cfDNA and nuclease biology10.1016/j.tig.2021.04.005 ↗
15. Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice10.1186/cc11442 ↗
16. Nucleic acid-binding polymers as anti-inflammatory agents10.1073/pnas.1105777108 ↗
17. Theranostic nucleic acid binding nanoprobe exerts anti-inflammatory and cytoprotective effects in ischemic injury10.7150/thno.17366 ↗
18. Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo10.1016/S0168-3659(99)00246-1 ↗
19. Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation10.1038/s41467-018-06603-5 ↗
20. Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers10.1126/sciadv.aay7148 ↗
21. The protein corona modulates the inflammation inhibition by cationic nanoparticles via cell-free DNA scavenging
22. Scavenging nucleic acid debris to combat autoimmunity and infectious disease10.1073/pnas.1607011113 ↗
23. Triggerable prodrug nanocoating enables on-demand activation of microbial and small-molecular therapeutics for combination treatment10.1021/jacs.3c10015 ↗
24. Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation10.1073/pnas.1003103107 ↗
25. Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury10.1186/s13054-021-03775-3 ↗
26. Macrophage biology in development, homeostasis and disease10.1038/nature12034 ↗
27. Macrophage development and polarization in chronic inflammation10.1016/j.smim.2015.07.002 ↗
28. Immunodesign of experimental sepsis by cecal ligation and puncture10.1038/nprot.2008.214 ↗
29. Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation10.1126/scitranslmed.aab3459 ↗
30. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis10.1073/pnas.0809422106 ↗
31. Pattern recognition receptors in health and diseases10.1038/s41392-021-00687-0 ↗
32. Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: new insight for treating COVID-1910.1016/j.redox.2021.102046 ↗
33. Bioinspired copper single-atom nanozyme as a superoxide dismutase-like antioxidant for sepsis treatment
34. Polydopamine nanoparticles as efficient scavengers for reactive oxygen species in periodontal disease10.1021/acsnano.8b04022 ↗
35. Near-infrared light-activatable, analgesic nanocomposite delivery system for comprehensive therapy of diabetic wounds in rats10.1016/j.biomaterials.2024.122467 ↗
36. Dual reactive oxygen species generator independent of light and oxygen for tumor imaging and catalytic therapy10.31635/ccschem.021.202101103 ↗
37. Role of polydopamine's redox-activity on its pro-oxidant, radical-scavenging, and antimicrobial activities10.1016/j.actbio.2019.02.032 ↗
38. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets10.1016/j.intimp.2020.107087 ↗
39. Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells10.1002/adma.201202211 ↗
40. Circulating cell-free DNAs as a biomarker and therapeutic target for acetaminophen-induced liver injury
41. Macrophage polarization in inflammatory diseases10.7150/ijbs.8879 ↗
42. Diversity, mechanisms, and significance of macrophage plasticity10.1146/annurev-pathmechdis-012418-012718 ↗
43. Macrophages-regulating nanomedicines for sepsis therapy10.1016/j.cclet.2022.06.011 ↗
44. A general and efficient strategy for gene delivery based on tea polyphenols intercalation and self-polymerization
45. Tea polyphenol nanoparticles enable targeted siRNA delivery and multi-bioactive therapy for abdominal aortic aneurysms10.1186/s12951-024-02756-2 ↗
46. DNA origami as a nanomedicine for targeted rheumatoid arthritis therapy through reactive oxygen species and nitric oxide scavenging10.1021/acsnano.2c03991 ↗
47. Antiviral and anti-Inflammatory treatment with multifunctional alveolar macrophage-Like nanoparticles in a surrogate mouse model of COVID-19
48. Sepsis: preventing organ failure in sepsis - the search continues10.1038/nrneph.2016.171 ↗
49. Sepsis and septic shock10.1016/S0140-6736(18)30696-2 ↗
50. Combination therapy with resveratrol and celastrol using folic acid-functionalized exosomes enhances the therapeutic efficacy of sepsis
51. Targeting multiple mediators of sepsis using multifunctional tannic acid-Zn2+-gentamicin nanoparticles10.1016/j.matt.2021.09.001 ↗
52. Soluble CD4 effectively prevents excessive TLR activation of resident macrophages in the onset of sepsis10.1038/s41392-023-01438-z ↗
53. Sustainable nanosheet antioxidants for sepsis therapy via scavenging intracellular reactive oxygen and nitrogen species10.1021/acsnano.0c03807 ↗
54. Exosome-based mitochondrial delivery of circRNA mSCAR alleviates sepsis by orchestrating macrophage activation10.1002/advs.202205692 ↗
55. Prognostic utility and characterization of cell-free DNA in patients with severe sepsis10.1186/cc11466 ↗
56. Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy10.1186/s13045-023-01512-7 ↗
57. Intrinsic radical species scavenging activities of tea polyphenols nanoparticles block pyroptosis in endotoxin-induced sepsis10.1021/acsnano.1c08913 ↗